Pfizer CEO Bails On EU Testimony After Report Highlights ‘Secretive’ Vaccine Deal
Pfizer CEO Albert Bourla has bailed on an appointment to testify before the European Parliament’s special committee, where he was expected to face tough questions over secretive vaccine deals, Politico reports.
Bourla was scheduled to appear before the panel on Oct. 10, alongside key officials involved in the EUs vaccine procurement process, in order to discuss how to respond to future pandemics. According to the report, “Other pharmaceutical executives have addressed the committee, including the CEO of Moderna and senior officials from AstraZeneca and Sanofi.”
Bourla? Not so much.
The committee’s chair, Belgian MEP Kathleen Van Brempt, told POLITICO she “deeply regrets” the decision taken by Pfizer.
After a visit to BioNTech’s headquarters last week, Van Brempt had said in a written statement that she looked forward to discussions “with other CEOs” including “Mr. Albert Bourla, the CEO of Pfizer” on October 10. -Politico
In early September, an audit repirt into the EU’s vaccine procurement strategy raised questions over Bourla’s relationship with European Commission President Ursula von der Leyen before they struck a multibillion-euro vaccine deal.
The report, by the European Court of Auditors, found that von der Leyen had been directly involved in preliminary negotiations for the EU’s biggest vaccine contract, for up to 1.8 billion doses of the BioNTech/Pfizer vaccine, which was concluded in May 2021. This was a departure from the negotiating procedure followed with other contracts, where a joint negotiating team made up of officials from the Commission and member countries conducted exploratory talks. -Politico
In April, von der Leyen admitted that she had been texting with Bourla for a month straight while they were negotiating the massive contract. Two months later, the texts disappeared, triggering accusations of maladministration by the EU’s ombudsman, Emily O’Reilly,” Reuters reported at the time.
Bourla and von der Leyen’s cozy relationship was noted last year by the NYT, which Bourla told they had “developed a deep trust, because we got into deep discussions.”
“She knew details about the variants, she knew details about everything. So that made the discussion, way more engaged.”
And now Bourla won’t have to answer questions about it.
This post was originally published at Zero Hedge
(TLB) published this article from Summit News
Header featured image (edited) credit: Bourla/ FABRICE COFFRINI/AFP via Getty Images
Emphasis added by (TLB) editors
Stay tuned to …
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.